Sun Pharma tries to limit damage - News Summed Up

Sun Pharma tries to limit damage


The whistleblower had alleged that Sun Pharma’s distributor Aditya Medisales Ltd had transactions worth more than Rs 5,800 crore with Suraksha Realty, controlled by executive director Sudhir Valia. Sun Pharma had said it had not received the complaint and was not privy to the contents of the document. On loans or guarantees to Suraksha Realty, Sun Pharma said, “neither any loans nor guarantees have been given to Suraksha Realty. Sun Pharma would like to dispel all falsehoods being spread about its financial dealings with Suraksha Realty. The company states unequivocally that it does not have any financial transactions with Suraksha Realty”.


Source: The Telegraph January 22, 2019 19:52 UTC



Loading...

Loading...